Second line chemotherapy in small cell lung cancer
- 1 December 1989
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 5 (4-6) , 207-213
- https://doi.org/10.1016/0169-5002(89)90169-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Identification of new drugs in pretreated patients with small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)European Journal of Cancer and Clinical Oncology, 1988
- First-line chemotherapy rechallenge after relapse in small cell lung cancerCancer Chemotherapy and Pharmacology, 1988
- Reinduction chemotherapy in small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1987
- VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancerCancer, 1984
- Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapyCancer Chemotherapy and Pharmacology, 1982
- Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimensCancer, 1981
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979
- Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)Cancer, 1977